Serum concentrations of pegylated interferon α-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon α-2b in a randomized phase III trial (EORTC 18991)

被引：0
|
作者：
Alexander M. M. Eggermont
Marna G. Bouwhuis
Wim H. Kruit
Alessandro Testori
Timo ten Hagen
Antoine Yver
Christine Xu
机构：
[1] Erasmus University Medical Center,Department of Surgical Oncology
[2] Daniel den Hoed Cancer Center,Department of Medical Oncology
[3] Erasmus University Medical Center,Melanoma/Sarcoma Unit
[4] Daniel den Hoed Cancer Center,undefined
[5] European Institute of Oncology,undefined
[6] Schering-Plough Research Institute,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词：
Peginterferon alfa-2b; Melanoma; Pharmacokinetics; Cytokines;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：671 / 677
页数：6
相关论文
共 50 条
  • [21] Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
    Egberts, F.
    Gutzmer, R.
    Ugurel, S.
    Becker, J. C.
    Trefzer, U.
    Degen, A.
    Schenck, F.
    Frey, L.
    Wilhelm, T.
    Hassel, J. C.
    Schadendorf, D.
    Livingstone, E.
    Mauch, C.
    Garbe, C.
    Berking, C.
    Rass, K.
    Mohr, P.
    Kaehler, K. C.
    Weichenthal, M.
    Hauschild, A.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (07) : 1667 - 1674
  • [22] Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma
    Hwu, Wen-Jen
    PanageaS, Katherine S.
    Menell, Jennifer H.
    Lamb, Lynne A.
    Aird, Suzan
    Krown, Susan E.
    Williams, Linda J.
    Chapman, Paul B.
    Livingston, Philip O.
    Wolchok, Jedd D.
    Houghton, Alan N.
    [J]. CANCER, 2006, 106 (11) : 2445 - 2451
  • [23] Quality of life in melanoma patients during adjuvant treatment with pegylated interferon-α2b: patients' and doctors' views
    Loquai, Carmen
    Schmidtmann, Irene
    Beutel, Manfred
    Sunderkoetter, Cord
    Grabbe, Stephan
    Schiller, Meinhard
    Nashan, Dorothee
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (06) : 976 - 984
  • [24] A randomized trial of pegylated interferon α-2b plus ribavirin in the retreatment of chronic hepatitis C
    Jacobson, IM
    Gonzalez, SA
    Ahmed, F
    Lebovics, E
    Min, AD
    Bodenheimer, HC
    Esposito, SP
    Brown, RS
    Bräu, N
    Klion, FM
    Tobias, H
    Bini, EJ
    Brodsky, N
    Cerulli, MA
    Aytaman, A
    Gardner, PW
    Geders, JM
    Spivack, JE
    Rahmin, MG
    Berman, DH
    Ehrlich, J
    Russo, MW
    Chait, M
    Rovner, D
    Edlin, BR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (11): : 2453 - 2462
  • [25] Adjuvant pembrolizumab versus high-dose interferon α-2b for Chinese patients with resected stage III melanoma: a retrospective cohort study
    Tao Li
    Dong-Dong Jia
    Li-Song Teng
    [J]. Investigational New Drugs, 2020, 38 : 1334 - 1341
  • [26] Adjuvant pembrolizumab versus high-dose interferon α-2b for Chinese patients with resected stage III melanoma: a retrospective cohort study
    Li, Tao
    Jia, Dong-Dong
    Teng, Li-Song
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1334 - 1341
  • [27] Effects of Pegylated Interferon α2b on Metastasis of Hepatocellular Carcinoma
    Arakawa, Yusuke
    Shimada, Mitsuo
    Utsunomiya, Tohru
    Imura, Satoru
    Morine, Yuji
    Ikemoto, Tetsuya
    [J]. JOURNAL OF SURGICAL RESEARCH, 2012, 172 (01) : 95 - 101
  • [28] The comparison of the efficacy of pegylated interferon α-2a and α-2b in chronic hepatitis B patients
    Dogan, Umit B.
    Golge, Necmettin
    Akin, Mustafa S.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (11) : 1312 - 1316
  • [29] Concurrent adjuvant radiotherapy and interferon-α2b for resected high risk stage III melanoma -: a retrospective single centre study
    Gyorki, DE
    Ainslie, J
    Joon, ML
    Henderson, MA
    Millward, M
    McArthur, GA
    [J]. MELANOMA RESEARCH, 2004, 14 (03) : 223 - 230
  • [30] Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatitis C in HIV patients
    Cargnel, A
    Angeli, E
    Mainini, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, P
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A766 - A766
12345